Highlights of the important and interesting in the world of healthcare:
Collaborate or die. International consulting firm PricewaterhouseCoopers says biotechnology companies must collaborate to produce more efficient and cost-effective medicines or face extinction in a new report called Biotech Reinvented.
Data could predict serious illnesses. The Office of Personnel Management intends to create a giant database of medical claims information about federal employees and enrollees in two programs created by health reform law so it can find patterns to help predict and prevent serious and costly illnesses, though health privacy advocates are concerned, according to American Medical News.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
GOP spending cuts to fight health reform law? As they seek to make good on their campaign promise to roll back President Obama’s healthcare overhaul, the incoming Republican leaders in the House say they intend to use their new muscle to cut off money for the law, setting up a series of partisan clashes and testing Democratic commitment to the legislation, according to the New York Times.
Pfizer arthritis drug has market promise. Pfizer Inc.’s experimental pill for rheumatoid arthritis, tasocitinib, reduced pain and inflammation without unforeseen side effects in a study that may help the company supplant injectable drugs with $12 billion in yearly sales, Bloomberg Businessweek reports.
Express Scripts could cut 1,000 jobs. Express Scripts could cut 992 jobs in two facilities in the Philadelphia area if negotiations with a union fail, according to the Pharmalot blog.
Cleveland Clinic model of efficiency. Kaleida Health in Buffalo, New York, has hired the Cleveland Clinic to offer excellence and cost-efficiency advice on its heart-care program, including its policies, procedures, personnel, outcomes and facilities, according to the Buffalo News.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Forum Health buyer extends $1.5B in debt. Community Health Systems Inc. (NYSE:CYH), the Tennessee for-profit hospital company that recently completed a $120 million purchase of bankrupt Forum Health in Youngstown, Ohio, has negotiated a two-and-a-half-year extension for $1.5 billion in bank debt.
